An Overview of Gynecologic Cancers, Their Management and the Role of Robotic Surgery in Delhi NCR India
About Dr Parminder Kaur
Dr. Parminder Kaur is a recent addition to Dr Mandeep’s team. She is a certified gynecologic oncologist in Delhi NCR with extensive experience in both conventional and laproscopic surgery. Dr Mandeep has mentored her in acquiring skills of Robotic surgery. Renowned for her technical expertise and compassionate patient care, she combines cutting‑edge technology with a deep understanding of women’s health to provide optimal outcomes for patients with malignancies of the female reproductive tract.
Know about Gynecologic Cancers – Spectrum and Clinical Presentation
Gynecologic malignancies arise from the organs of the female reproductive system, namely:
| Organ | Common Cancer Types |
| Uterus (Endometrium) | Endometrial carcinoma |
| Cervix | Cervical carcinoma |
| Ovaries & Fallopian Tubes | Epithelial ovarian carcinoma, primary tubal carcinoma |
| Vagina | Vaginal carcinoma (rare) |
| Vulva | Vulvar carcinoma (rare) |
Epidemiology
- In India, cervical cancer (India alone reported 127,526 new cases and 79,906 fatalities in 2022, contributing 29.59 % of global cervical cancer cases and 34.12 % of deaths. ) remains the most common gynaecologic malignancy, whereas in many Western populations endometrial cancer predominates.
- Although most cancers are diagnosed in post‑menopausal women, a significant proportion of ovarian and, occasionally, cervical cancers affect younger women.
Typical Symptoms
| Cancer | Early / Typical Symptoms |
| Endometrial (Uterine) Cancer | Post‑menopausal or abnormal uterine bleeding |
| Cervical Cancer | Post‑menopausal bleeding, foul‑smelling vaginal discharge, post‑coital bleeding |
| Ovarian Cancer | Abdominal bloating or distension, early satiety, loss of appetite, pelvic or abdominal pain (often late presentation) |
| Vaginal Cancer | Vaginal bleeding, discharge |
| Vulvar Cancer | Chronic pruritus, ulcerated or bleeding lesions, sometimes mimicking dermatologic conditions |
Early recognition of these signs is crucial for timely diagnosis and treatment.
Our Treatment Approach
Surgery – The Cornerstone
Surgical resection is the primary treatment for early‑stage gynecologic cancers. The extent of surgery depends on the organ involved, disease stage, and the need for clear oncologic margins.
- Uterine (Endometrial) Cancer – Total hysterectomy with bilateral salpingo‑oophorectomy (TSO) is standard; for higher‑risk disease, a radical hysterectomy (type I or type II) with parametrial resection is performed.
- Cervical Cancer – Radical hysterectomy (type III) with pelvic lymphadenectomy is indicated for early stages (IA‑IB).
- Ovarian Cancer – Comprehensive staging surgery includes TSO, omentectomy, peritoneal washings, and pelvic/para‑aortic lymph node assessment.
- Vaginal & Vulvar Cancers – Wide local excision or radical vaginectomy/ vulvectomy with appropriate nodal assessment.
Adjuvant Therapy
Post‑operative pathology guides the need for adjuvant chemotherapy, radiotherapy, or combined chemoradiation. High‑risk pathological features (e.g., deep myometrial invasion, lymph‑vascular space invasion, positive nodes) often mandate systemic therapy.
Lymph Node Evaluation
Accurate nodal staging is pivotal because nodal status is a powerful prognostic factor and influences adjuvant treatment decisions.
- Traditional Approach – Complete pelvic (and when indicated, para‑aortic) lymphadenectomy. While thorough, it carries risks of vascular, ureteric, and nerve injury, as well as lymphedema.
- Sentinel Lymph Node (SLN) Mapping – Minimally invasive technique that identifies the first draining nodes. Using indocyanine green (ICG) dye and the Firefly imaging system on the DaVinci® robotic platform, SLNs are visualized in real time. Intra‑operative frozen section analysis determines nodal status; a negative SLN can obviate the need for full lymphadenectomy, thereby reducing morbidity without compromising oncologic safety.
Latest & Advanced Robotic Surgery – Advantages Over Conventional Techniques
| Feature | Conventional Laparoscopy | Robotic (DaVinci®) |
| Visualization | 2‑D optics | 3‑D high‑definition |
| Instrument Articulation | Limited (90°) | Wristed instruments with 7° of freedom |
| Ergonomics | Surgeon fatigue common | Comfortable seated console; tremor filtration |
| Learning Curve | Steep for complex pelvic work | Shortened for complex dissection (e.g., radical hysterectomy) |
| Outcomes | Small incisions, modest blood loss | Even less blood loss, precise margin control, reduced conversion rates |
| Recovery | Hospital stays 2‑4 days | Hospital stays often ≤ 2 days; faster return to normal activities |
Robotic platforms enable the surgeon to perform meticulous dissection around critical structures (ureters, pelvic vasculature, nerves) with enhanced precision. This is especially valuable in:
- Radical hysterectomy – Enabling thorough parametrial and vaginal cuff removal while preserving surrounding neurovascular bundles.
- Pelvic lymphadenectomy / SLN mapping – Facilitating delicate exposure of nodal basins and accurate fluorescent imaging.
- Ovarian cancer staging – Allowing comprehensive peritoneal evaluation and omentectomy through small ports.
Pre‑operative Assessment
All patients undergo a thorough work‑up that includes:
- Radiologic Staging – MRI of the pelvis (and CT/PET‑CT when indicated) to delineate tumor extent and nodal involvement.
- Laboratory Evaluation – CBC, renal and hepatic panels, tumor markers (CA‑125 for ovarian lesions).
- Multidisciplinary Review – Presentation at tumor board to finalize the surgical plan and anticipate adjuvant therapy needs.
Clinical Outcomes
- Oncologic Adequacy – Robotic surgery achieves comparable (and often superior) negative‑margin rates and nodal yields to open surgery.
- Morbidity – Decreased intra‑operative blood loss, lower transfusion rates, and reduced postoperative pain.
- Functional Recovery – Shorter hospital stay, faster return to daily activities, and lower incidence of lymphedema when SLN mapping is employed.
- Survival – Long‑term disease‑free survival mirrors that of traditional approaches, affirming the oncologic safety of minimally invasive techniques.
Conclusion
Gynecologic cancers require a nuanced, multidisciplinary approach. Surgery remains the cornerstone of curative therapy, and when performed with modern robotic technology, it offers superior precision, reduced morbidity, and rapid recovery without compromising oncologic outcomes.
If you or a loved one are facing a diagnosis of a gynecologic malignancy, our team—led by Dr. Parminder Kaur—stands ready to provide comprehensive evaluation, state‑of‑the‑art robotic surgery in Delhi NCR, and coordinated adjuvant care. We invite you to contact our Patient Care Coordinator at (+91 99714 74985) to discuss personalized treatment options and to schedule a consultation.
